Quoin Pharmaceuticals Ltd - ADR

NASDAQ:QNRX   4:00:00 PM EDT
1.75
+0.02 (+1.16%)
7:52:15 PM EDT: $1.78 +0.03 (+1.71%)
Earnings Announcements

Quoin Pharmaceuticals Provides Third Quarter Results

Published: 11/10/2022 15:16 GMT
Quoin Pharmaceuticals Ltd - ADR (QNRX) - Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2022 Financial Results.
Ended Q3 With Approximately $15.2 Million in Cash and Marketable Securities.
Qtrly Loss per Share per Ads $4.65.
Q3 Earnings per Share View $-1.35 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.